Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Recurrence 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasm, Residual 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1

Interventions

blinatumomab 3Cytarabine 2Cyclophosphamide 2Azacitidine 2venetoclax 1sabatolimab 1ruxolitinib 1pulrodemstat besilate 1pembrolizumab 1peginterferon alfa-2a 1nilotinib 1fludarabine 1daratumumab 1Zoledronic Acid 1Vitamin D 1Methotrexate 1Imatinib Mesylate 1GNKG168 1Dasatinib 1Clofarabine 1Celecoxib 1Calcium 1CD3 Complex 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Neoplasm, Residual × GNKG168 × Clear all
NCT01743807 2025-01-27

Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia

Therapeutic Advances in Childhood Leukemia Consortium

Phase 1 Terminated
4 enrolled 6 charts
LymphoidOther hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡